Functional Status and Body Mass Index in Postmenopausal Women with Fibromyalgia: A Case–control Study

Cerón-Lorente, Laura; Ríos, María del Carmen García; Navarro-Ledesma, Santiago; Tapia-Haro, Rosa María; Barragán, Antonio Casas; Correa‐Rodríguez, María; Ferrándiz, María Encarnación Aguilar

doi:10.3390/ijerph16224540

Cited by 15 publications

(15 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Finally, in another recent study of 34 postmenopausal women with FM and 22 healthy controls classified on the basis of their BMI [ 25 ], the patients with FM reported worse dynamic and static balance, poorer functional mobility and higher levels of physical disability regardless of their nutritional status, which suggests that BMI probably does not play a major role in the impaired functional capacity of postmenopausal patients with FM.…”

Section: Discussionmentioning

confidence: 99%

The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients

Atzeni

Alciati²,

Salaffi

et al. 2021

Rheumatology Advances in Practice

View full text Add to dashboard Cite

Objective Various studies have shown that overweight and obesity are central features of fibromyalgia syndrome (FM), but the real impact of a high body mass index (BMI) on clinical severity in patients with FM is still controversial. The aim of this study was to analyse the relationships between BMI categories and measures of symptom severity and functional impairment using data from a web-based registry of patients with FM. Methods Adult patients with an ACR 2010/2011 diagnosis of FM underwent a complete physical examination and laboratory tests, and were asked to complete a package of questionnaires covering their sociodemographic and treatment details, as well as the following disease-specific questionnaires: the revised Fibromyalgia Impact Questionnaire (FIQR), the modified Fibromyalgia Assessment Status (ModFAS) questionnaire, and the Polysymptomatic Distress Scale (PDS). Results A total of 2339 patients were recruited and divided into two weight categories, Underweight/Normal (U/N, n = 1127, 48.39%) and Overweight/Obese (O/O, n = 1212, 51.81%). The total and subscale of FIQR, ModFAS and PSD scores were significantly higher in the O/O patients, as were all of the mean scores of the individual FIQR items (p < 0.001 for all). Conclusion Our findings demonstrate that O/O patients with FM are significantly more impaired in all of the symptomatological and functional domains as measured using the FIQR, ModFAS and PDS than U/N patients, thus suggesting that being O/O has an additional effect on symptoms and function.

show abstract

Section: Discussionmentioning

confidence: 99%

The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients

Atzeni

Alciati²,

Salaffi

et al. 2021

Rheumatology Advances in Practice

View full text Add to dashboard Cite

show abstract

“…Fibromyalgia syndrome (FMS) is a multi-faceted and chronic disease of unknown etiology [ 1 ] characterized by generalized pain tender points and psychosomatic symptoms, such as tiredness, rigidity, sleep perturbations or psychological disorders [ 2 , 3 ]. FMS has been related to increased sensitivity of the Central Nervous System (CNS) to pain marks [ 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

Alteration of Postural Balance in Patients with Fibromyalgia Syndrome—A Systematic Review and Meta-Analysis

et al. 2021

View full text Add to dashboard Cite

Balance problems are one of the most frequent symptoms in patients with Fibromyalgia Syndrome (FMS). However, the extent and nature of this balance disorder are not known. The objective of this work was to determine the best evidence for the alteration of postural balance in patients with FMS and analyze differences with healthy controls. To meet this objective, a systematic review with meta-analysis was performed. A bibliographical search was carried out in PubMed Medline, Scopus, Web of Science, CINAHL and SciELO. Observational studies that assessed postural balance in patients with FMS compared to healthy subjects in baseline conditions, were selected. In a random-effect model, the pooled effect was calculated with the Standardized Mean Difference (SMD) and its 95% confidence interval (CI). Nineteen studies reporting data of 2347 participants (95% female) were included. FMS patients showed poor balance with a large effect on static (SMD = 1.578; 95% CI = 1.164, 1.992), dynamic (SMD = 0.946; 95% CI = 0.598, 1.294), functional balance (SMD = 1.138; 95% CI = 0.689, 1.588) and on balance confidence (SMD = 1.194; 95% CI = 0.914, 1.473). Analysis of the Sensory Organization Test showed large alteration of vestibular (SMD = 1.631; 95% CI = 0.467, 2.795) and visual scores (SMD = 1.317; 95% CI = 0.153, 2.481) compared to healthy controls. Patients with FMS showed worse scores for different measures of postural balance compared to healthy controls. Concretely, FMS patients appear to have poor vestibular and visual scores with a possible somatosensory dependence.

show abstract

“…In addition to pain, presence of tender points and central sensitisation, other postural, balance and functional symptoms have also been presented in those with FMS [4,[12][13][14] affecting psychological health, ability to enjoy leisure activities and consequently quality of life [12,15,16]. It is therefore important to also include outcome measures of these symptoms in investigative research.…”

Section: Introductionmentioning

confidence: 99%

Short- and Long-term Effects of Photobiomodulation on Pain, Functionality, Tissue Quality, Central Sensitisation and Psychological Factors in a Population Suffering From Fibromyalgia: Protocol for a Triple-blinded Randomized Clinical Trial.

Navarro-Ledesma

Carroll²,

Burton³

2021

Preprint

View full text Add to dashboard Cite

Background: The development of an integral and global treatment to improve the quality of life in those with fibromyalgia syndrome (FMS) is challenging.Methods: This study is a randomized, placebo-controlled clinical trial. Participants will be recruited in a private care practice and randomized to receive either a whole body Photobiomodulation (PBM) therapy program or placebo. Primary out comes will be pain (NumericPain Rating Scale; Widespread Pain Index; Symptom Severity Score), functionality (Fibromyalgia Impact Questionnaire; The Leisure Time Physical Activity Instrument), quality of soft tissue (elastography) and central sensitisation (pain pressure threshold and the Autonomic Symptom Profile). Secondary outcomes will be psychological factors (Pain Catastrophising scale, Tampa Scale, Self-Efficay questionnaire). Assessments will be at baseline (T1), after session 6 (T2), after treatment (T3) and 2 weeks (T4), 3 (T5) and 6 (T6) month´ follow-up.Discussion: PBM therapy has been shown to reduce pain and inflammation and to increase the rate of tissue repair for a wide range of conditions, but its potential use as a whole body treatment in FM is yet to be explored. This trial will investigate whether whole body PBM therapy is effective at reducing pain intensity, improving functionality, quality of soft tissue, central sensitisation symptoms and psychological measurements. Furthermore, 3 and 6 months follow up will investigate long-term efficacy of this treatment.Trial registration: NCT04248972. Registered on January 29, 2020, https://clinicaltrials.gov/ct2/show/NCT04248972?term=navarro-ledesma+santiago&draw=2&rank=2.

show abstract

Functional Status and Body Mass Index in Postmenopausal Women with Fibromyalgia: A Case–control Study

Cited by 15 publications

References 39 publications

The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients

The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients

Alteration of Postural Balance in Patients with Fibromyalgia Syndrome—A Systematic Review and Meta-Analysis

Short- and Long-term Effects of Photobiomodulation on Pain, Functionality, Tissue Quality, Central Sensitisation and Psychological Factors in a Population Suffering From Fibromyalgia: Protocol for a Triple-blinded Randomized Clinical Trial.

Contact Info

Product

Resources

About